← back to search

Birte Hellwig

Zimmer Biomet (Netherlands) · NL
🔎 Find collaborators in Molecular Biology · Oncology →
Search 5.9M scientists by topic, h-index, country & funding — free.
Area of research
Molecular Biology · Oncology
Research interest
Research interests include Gene expression and cancer classification, Radiomics and Machine Learning in Medical Imaging, Cancer Immunotherapy and Biomarkers, and Lung Cancer Treatments and Mutations.
h-index
19
citations
2,053
works
80
NIH funding
primary concept
email

Recent publications

Early versus late response to PD-1-based immunotherapy in metastatic melanoma
European Journal of Cancer 2024cited by 7position: middledoi
Inhibiting the glycerophosphodiesterase EDI3 in ER-HER2+ breast cancer cells resistant to HER2-targeted therapy reduces viability and tumour growth
Journal of Experimental & Clinical Cancer Research 2023cited by 34position: middledoi
Identification of an FXR-modulated liver-intestine hybrid state in iPSC-derived hepatocyte-like cells
Journal of Hepatology 2022cited by 17position: middledoi
LIPG‐promoted lipid storage mediates adaptation to oxidative stress in breast cancer
International Journal of Cancer 2019cited by 48position: middledoi
Assessment of stem cell differentiation based on genome-wide expression profiles
Philosophical Transactions of the Royal Society B Biological Sciences 2018cited by 29position: middledoi
Loss of circadian clock gene expression is associated with tumor progression in breast cancer
Cell Cycle 2014cited by 234position: middledoi
The prognostic relevance of tumour-infiltrating plasma cells and immunoglobulin kappa C indicates an important role of the humoral immune response in non-small cell lung cancer
Cancer Letters 2013cited by 230position: middledoi
Biomarker Discovery in Non–Small Cell Lung Cancer: Integrating Gene Expression Profiling, Meta-analysis, and Tissue Microarray Validation
Clinical Cancer Research 2012cited by 382position: middledoi
A Comprehensive Analysis of Human Gene Expression Profiles Identifies Stromal Immunoglobulin κ C as a Compatible Prognostic Marker in Human Solid Tumors
Clinical Cancer Research 2012cited by 261position: middledoi
Interferon-inducible guanylate binding protein (GBP2) is associated with better prognosis in breast cancer and indicates an efficient T cell response
Breast Cancer 2012cited by 104position: middledoi
Expression of aurora kinase A is associated with metastasis-free survival in node-negative breast cancer patients
BMC Cancer 2012cited by 97position: middledoi

Grants

No grants ingested yet.

Frequent collaborators

Jan G. Hengstler · League Against Cancer8 papers (2012–2023)Jörg Rahnenführer · TU Dortmund University8 papers (2012–2023)Cristina Cadenas · TU Dortmund University6 papers (2012–2023)Rosemarie Marchan · TU Dortmund University6 papers (2012–2023)Karolina Edlund · TU Dortmund University5 papers (2012–2023)Miriam Lohr · Freie Universität Berlin4 papers (2012–2014)Marcus Schmidt · Universitäts Frauenklinik3 papers (2012–2023)Patrício Godoy · Austral University of Chile3 papers (2012–2022)Mats Lambe · Karolinska Institutet2 papers (2012–2013) · 2 papers (2018–2022)Patrick Micke · Uppsala University2 papers (2012–2013)Jörn Walter · FORTH Institute of Computer Science2 papers (2018–2022)Nils Blüthgen · German Cancer Research Center2 papers (2018–2022)Johan Botling · Uppsala University2 papers (2012–2013)Anders Berglund · Uppsala University2 papers (2012–2013)Lars Holmberg · Uppsala University2 papers (2012–2013) · 2 papers (2018–2022)Fredrik Pontén · Uppsala University2 papers (2012–2013)Simon Ekman · Karolinska University Hospital2 papers (2012–2013) · 2 papers (2018–2022)
Looking for a research collaborator?
Search millions of scientists by field, institution, impact, and funding status — see their work, find their email, and reach out directly.
Find collaborators in Molecular Biology · Oncology →